Bollard Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-14,235
Closed -$2.92M 270
2017
Q3
$2.92M Buy
14,235
+35
+0.2% +$8.14K 0.15% 81
2017
Q2
$3.45M Hold
14,200
0.19% 70
2017
Q1
$3.39M Hold
14,200
0.19% 72
2016
Q4
$2.98M Hold
14,200
0.19% 69
2016
Q3
$3.27M Buy
14,200
+4,200
+42% +$1.03M 0.21% 64
2016
Q2
$2.31M Buy
+10,000
New +$2.31M 0.16% 78

Other funds holding AGN

Bollard Group's AGN Position: Q4 2017 in Review

Bollard Group sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 14,235 shares — an estimated $2.92M sold.

Bollard Group first reported a position in AGN in Q2 2016 and held it in 6 quarters. The position peaked at $3.45M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Bollard Group reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Bollard Group sold 14,235 Allergan plc shares in Q4 2017, an estimated $2.92M.
  • Bollard Group first reported a position in Allergan plc in Q2 2016 and held it in 6 quarters.
  • Bollard Group's Allergan plc position peaked at $3.45M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Bollard Group's 13F filing for Q4 2017, filed 29 Jan 2018.